Mufg Securities Americas Inc. Makes New $808,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Mufg Securities Americas Inc. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,693 shares of the company's stock, valued at approximately $808,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Norges Bank purchased a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $840,286,000. Royal London Asset Management Ltd. lifted its position in HCA Healthcare by 62.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after acquiring an additional 574,239 shares in the last quarter. Barclays PLC lifted its position in HCA Healthcare by 85.7% in the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after acquiring an additional 489,916 shares in the last quarter. Principal Financial Group Inc. lifted its position in HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after acquiring an additional 476,756 shares in the last quarter. Finally, Consulta Ltd lifted its position in HCA Healthcare by 100.0% in the 4th quarter. Consulta Ltd now owns 550,000 shares of the company's stock valued at $165,082,000 after acquiring an additional 275,000 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock traded up $1.99 during trading on Friday, reaching $387.49. The company's stock had a trading volume of 1,789,678 shares, compared to its average volume of 1,430,021. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $93.22 billion, a P/E ratio of 17.64, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The company's fifty day moving average is $340.72 and its 200-day moving average is $328.51.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the business posted $5.36 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.74%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Ratings Changes

Several research firms recently issued reports on HCA. Barclays lowered their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. StockNews.com raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Bank of America lowered their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $381.13.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.